drugset / Trial / NCT03136666
Single Dose Escalation Study to Investigate the Pharmacokinetics as Well as Safety and Tolerability of a Concomitant Administration of Nifedipne GITS and Candesartan Tablets Under Fasting Conditions in Healthy Male Subjects in an Open Label, Non-randomized, Sequential Design.
NaSingle-groupOpen-labelTreatment
Summary
The objective of the study was to investigate the pharmacokinetics as well as safety and tolerability of a concomitant administration of nifedipine GITS and candesartan tablets under fasting conditions in healthy male subjects.
Timeline
- Start
- 2010-04-19
- Primary completion
- 2010-06-07
- Completion
- 2010-06-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Candesartan cilexetil | Unknown | 8 mg | Oral |
| Subject | Candesartan cilexetil | Unknown | 16 mg | Oral |
| Subject | Candesartan cilexetil | Unknown | 32 mg | Oral |
| Subject | Nifedipine | Other / unclassified | 30 mg | Oral |
| Subject | Nifedipine | Other / unclassified | 60 mg | Oral |
Indications
No indication recorded.